Molecular Approach to Targeted Therapy for Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|1|20-34

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.1, 2016-02, pp. : 20-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3215-3222

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Antioxidative Therapy of Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. : 4720-4730

Bentham Science Publishers

Access to resources Recommend Favorite

Teriflunomide for oral therapy in multiple sclerosis

By Papadopoulou Athina   Kappos Ludwig   Sprenger Till  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 617-628

Informa Healthcare

Access to resources Recommend Favorite

Basic and escalation therapy of multiple sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 414-421

Govi-Verlag

Access to resources Recommend Favorite

Managing the Adverse Effects of Interferon- Therapy in Multiple Sclerosis

By Bayas A.   Rieckmann P.  

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 149-159

Adis International

Access to resources Recommend Favorite